Telangiectasis: Clinical Trials

2 trials for Telangiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 2
Phase 21Unknown 1

Follow Telangiectasis: new trials by email Literature Review of Telangiectasis trials Research Report on Telangiectasis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia
Pazopanib - Hereditary Hemorrhagic Telangiectasia, Epistaxis
Phase 1 / Phase 2UnknownCure HHT302023-07-012022-09-08
Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects
GTX-102 medium dose fast Period 1 and Period 2, GTX-102 medium dose slow Period 1 and Period 2, GTX-102 high dose fast Period 1 and Period 2 - Ataxia Telangiectasia
Phase 1UnknownGrace Therapeutics Inc.482022-09-132023-01-23

Narrower conditions

Ataxia Telangiectasia (1)  ·  Epistaxis (1)  ·  Telangiectasia, Hereditary Hemorrhagic (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Vascular Diseases (2)  ·  Ataxia (1)  ·  Brain Diseases (1)  ·  Cardiovascular Abnormalities (1)  ·  Central Nervous System Diseases (1)  ·  Cerebellar Ataxia (1)  ·  Cerebellar Diseases (1)  ·  Congenital Abnormalities (1)  ·  DNA Repair-Deficiency Disorders (1)  ·  Dyskinesias (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)

Interventions

pazopanib (1)

Sponsors

Cure HHT (1)  ·  Grace Therapeutics Inc. (1)

Countries

Canada (1)

Top investigators

Janice Faulknor, MD (1)  ·  Raj Kasthuri, MD (1)